Tolerability and Pharmacokinetics of a New P-Glycoprotein Inhibitor, HM30181, in Healthy Korean Male Volunteers: Single- and Multiple-Dose Randomized, Placebo-Controlled Studies
Latest Information Update: 14 Feb 2012
At a glance
- Drugs Encequidar+paclitaxel (Primary)
- Indications Cancer
- Focus Adverse reactions; Pharmacokinetics
- 25 Jan 2012 New trial record